您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Yihua Wang1,2, Qi Jia3, Hongxiu Liu1
1Second Hospital of Shanxi Medical University, Taiyuan, 030001, China.
放射治疗后的核糖体蛋白L29 (RPL29) 下调与多发性骨髓瘤 (MM) 的更好的结果相关. 这将RPL29确定为MM患者的潜在预后生物标志物.
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: